Published date: 14 September 2015

Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.


Approach to market date: 30 January 2016

Contract summary

Industry

  • Medical equipments, pharmaceuticals and personal care products - 33000000

  • Laboratory, optical and precision equipments (excl. glasses) - 38000000

Location of contract

EN6 3QG

Value of contract

£45,000

Procurement reference

P-1032

Published date

14 September 2015

Approach to market date

30 January 2016

Contract start date

31 March 2016

Contract end date

30 March 2017

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

We have a requirement to purchase 1 g of the following 5 recombinant antibodies in a custom made formulation (buffer to be defined at a later stage):

Anti-CD52 [Campath-1H], Human IgG1

Anti-CD3 epsilon [OKT-3 (muromonab)], Mouse IgG2A

Anti- Keyhole limpet hemocyanin (KLH), Mouse IgG2A

Anti-KLH, Human IgG1

Anti-KLH, Human IgG4

More information

Spend profile

This table displays the spend profile of the notice
Financial year Budget
2016/2017 £45,000

Attachments

Links

About the buyer

Contact name

Procurement

Address

Blanch Lane
South Mimms
Potters Bar
EN6 3QG
England

Telephone

01707 641 000

Email

purchasing@nibsc.org

Website

www.mhra.gov.uk